Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03611673 · ClinicalTrials.gov registry record · NA

At-Home Olfactory Training

A NA study, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT03611673: Completed NA study, sponsored by University of Kansas Medical Center.

NCT03611673 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03611673, a NA study, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

The purpose of this study is to determine the impact of a twice daily at-home olfactory training program with a twenty scent, essential oil-based smell test in patients with olfactory dysfunction.

Primary Outcome

Sniffin Sticks are a battery of 12 scents within a tube. The subject smells each scent and then chooses from 4 multiple choice options which is the scent they smelled. Increased number of correct responses indicates better sense of smell. 12/12 is the maximum score. 0/12 is the minimum score.

Interventions

  • OTHER Smell Test

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2018-06-02
Est. Completion 2021-04-19
Phase NA
University of Kansas Medical Center

408 total trials

What the finished NCT03611673 record still lists

NCT03611673 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Smell Test is the first listed.

NCT03611673 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03611673 about?

NCT03611673 is a clinical study titled "At-Home Olfactory Training". The purpose of this study is to determine the impact of a twice daily at-home olfactory training program with a twenty scent, essential oil-based smell test in patients with olfactory dysfunction.

What is the current status of trial NCT03611673?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2018-06-02. Estimated completion is 2021-04-19.

What interventions are being tested in trial NCT03611673?

The interventions under investigation include: Smell Test (OTHER).

Who is sponsoring clinical trial NCT03611673?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03611673's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03611673, the US trial registry maintained by the National Library of Medicine. NCT03611673 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.